You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR FENFLURAMINE HYDROCHLORIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for fenfluramine hydrochloride

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000313 ↗	Predictive Values of Serotonergic Alterations for Outcome - 2	Terminated	VA Office of Research and Development	Phase 1	1969-12-31	The purpose of this study is to evaluate the predictive value of serotonergic alterations for outcome.
NCT00000313 ↗	Predictive Values of Serotonergic Alterations for Outcome - 2	Terminated	National Institute on Drug Abuse (NIDA)	Phase 1	1969-12-31	The purpose of this study is to evaluate the predictive value of serotonergic alterations for outcome.
NCT00000314 ↗	M-CPP and Fenfluramine in Cocaine Addicts - 3	Completed	VA Office of Research and Development	Phase 2	1994-09-01	The purpose of this study is to evaluate predictive value of M-CPP and fenfluramine challenges for outcome.
NCT00000314 ↗	M-CPP and Fenfluramine in Cocaine Addicts - 3	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	1994-09-01	The purpose of this study is to evaluate predictive value of M-CPP and fenfluramine challenges for outcome.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for fenfluramine hydrochloride

Condition Name

Chart
Table

Condition Name for fenfluramine hydrochloride
Intervention	Trials
Dravet Syndrome	8
Lennox Gastaut Syndrome	4
Cocaine-Related Disorders	2
Obesity	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for fenfluramine hydrochloride
Intervention	Trials
Syndrome	9
Epilepsies, Myoclonic	8
Epilepsy	5
Lennox Gastaut Syndrome	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for fenfluramine hydrochloride

Trials by Country

Map
Table

Trials by Country for fenfluramine hydrochloride
Location	Trials
United States	83
Japan	15
Canada	12
Belgium	7
United Kingdom	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for fenfluramine hydrochloride
Location	Trials
California	6
Massachusetts	6
Washington	5
Minnesota	5
Illinois	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for fenfluramine hydrochloride

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for fenfluramine hydrochloride
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	10
Phase 2	5
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for fenfluramine hydrochloride
Clinical Trial Phase	Trials
Completed	6
Active, not recruiting	5
Recruiting	4
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for fenfluramine hydrochloride

Sponsor Name

Chart
Table

Sponsor Name for fenfluramine hydrochloride
Sponsor	Trials
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.	9
Zogenix, Inc.	4
VA Office of Research and Development	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for fenfluramine hydrochloride
Sponsor	Trials
Industry	15
Other	14
NIH	3
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.